BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30929921)

  • 21. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.
    Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK
    Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RPS24c Isoform Facilitates Tumor Angiogenesis
    Wang Y; Wu Y; Xiao K; Zhao Y; Lv G; Xu S; Wu F
    Curr Mol Med; 2020; 20(5):388-395. PubMed ID: 31797757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α.
    Xiang J; Sun H; Su L; Liu L; Shan J; Shen J; Yang Z; Chen J; Zhong X; Ávila MA; Yan X; Liu C; Qian C
    Cancer Lett; 2017 Aug; 400():117-126. PubMed ID: 28478181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4.
    Yang L; Hu S; Tan J; Zhang X; Yuan W; Wang Q; Xu L; Liu J; Liu Z; Jia Y; Huang X
    Oncotarget; 2016 Sep; 7(38):61562-61574. PubMed ID: 27528036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2.
    Hu HY; Yu CH; Zhang HH; Zhang SZ; Yu WY; Yang Y; Chen Q
    Int J Biol Macromol; 2019 Jul; 132():470-477. PubMed ID: 30936013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.
    Zhang F; Lu YX; Chen Q; Zou HM; Zhang JM; Hu YH; Li XM; Zhang WJ; Zhang W; Lin C; Li XN
    Cell Signal; 2017 Aug; 36():67-78. PubMed ID: 28455144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma.
    Palomero J; Vegliante MC; Rodríguez ML; Eguileor A; Castellano G; Planas-Rigol E; Jares P; Ribera-Cortada I; Cid MC; Campo E; Amador V
    Blood; 2014 Oct; 124(14):2235-47. PubMed ID: 25092176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 15-Lipoxygenase-1 re-expression in colorectal cancer alters endothelial cell features through enhanced expression of TSP-1 and ICAM-1.
    Tunçer S; Keşküş AG; Çolakoğlu M; Çimen I; Yener C; Konu Ö; Banerjee S
    Cell Signal; 2017 Nov; 39():44-54. PubMed ID: 28757355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
    Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
    Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progastrin a new pro-angiogenic factor in colorectal cancer.
    Najib S; Kowalski-Chauvel A; Do C; Roche S; Cohen-Jonathan-Moyal E; Seva C
    Oncogene; 2015 Jun; 34(24):3120-30. PubMed ID: 25109333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR6 promotes tumor angiogenesis via the AKT/NF-κB/VEGF pathway in colorectal cancer.
    Zhu CC; Chen C; Xu ZQ; Zhao JK; Ou BC; Sun J; Zheng MH; Zong YP; Lu AG
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):387-397. PubMed ID: 29097259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patrinia scabiosaefolia inhibits colorectal cancer growth through suppression of tumor angiogenesis.
    Chen L; Liu L; Ye L; Shen A; Chen Y; Sferra TJ; Peng J
    Oncol Rep; 2013 Sep; 30(3):1439-43. PubMed ID: 23820929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LIFR promotes tumor angiogenesis by up-regulating IL-8 levels in colorectal cancer.
    Wu HX; Cheng X; Jing XQ; Ji XP; Chen XZ; Zhang YQ; He YG; Liu K; Ye F; Sun HX; Gao HJ; Song ZJ; Wu H; Zhang XJ; Zhang T; Zhao R
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2769-2784. PubMed ID: 29751081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of hUTP14a in non-small cell lung cancer].
    Zhang CF; Liu Y; Lu M; DU XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):145-150. PubMed ID: 30773559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
    Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Lymphangiogenic Factor CCBE1 Promotes Angiogenesis and Tumor Growth in Colorectal Cancer.
    Ding W; Tang W; Zhi J
    Curr Mol Med; 2022; 22(9):819-825. PubMed ID: 34819004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonylphenol regulates TL1A through the AhR/HDAC2/HNF4α pathway in endothelial cells to promote the angiogenesis of colorectal cancer.
    Zhang T; Ning WW; Zhang J; Xu FJ; Wang XQ; Li ZB; Xie M
    Toxicol Appl Pharmacol; 2022 Feb; 436():115854. PubMed ID: 34974051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
    Cao F; Wang S; Wang H; Tang W
    Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4'-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling.
    Sun D; Zhang F; Qian J; Shen W; Fan H; Tan J; Li L; Xu C; Yang Y; Cheng H
    Chem Biol Interact; 2018 Dec; 296():26-33. PubMed ID: 30217479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.